Cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms in japanese children with infection-associated hemophagocytic lymphohistiocytosis

Acta Haematologica

Volumn 123, Issue 3, 2010, Pages 186-190

  Yoshiyama, Megumi ^a   Kounami, Shinji ^a   Nakayama, Keiko ^a   Okutani, Takahiro ^a   Aoyagi, Noriyuki ^a   Yoshikawa, Norishige ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

CTLA 4; Genetic polymorphisms; Hemophagocytic lymphohistiocytosis; Infection associated hemophagocytic lymphohistiocytosis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DINUCLEOTIDE REPEAT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HOMOZYGOSITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ALLELES; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFECTION; JAPAN; LACTATE DEHYDROGENASES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-2; STATISTICS AS TOPIC;

EID: 77950540046     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000295572     Document Type: Article

References (28)

1. Janka GE: Hemophagocytic syndromes. Blood Rev 2007; 21: 245-253.
2. Janka G, Stadt U: Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005, pp 82-88. (Pubitemid 46025500)
3. Fisman DN: Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6: 601-608.
4. Chang YH, Lee DS, Jo HS, Cho SI, Yoon HJ, Shin S, Yoon JH, Kim HY, Hong YJ, Hong SI, Cho HI: Tumor necrosis alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population. Cytokine 2006; 36: 45-50. (Pubitemid 46049020)
5. Zaitsu M, Yamamoto K, Ishii E, Teramura T, Nakadate N, Sako M, Sakata N, Wakiguchi H, Hirose M, Imayoshi M, Ogata Y, Imashuku S, Hamasaki Y, Yasukawa M: High frequency of QPY allele and linkage disequilibrium of granzyme-B in Epstein- Barr-virus-associated hemophagocytic lymphohistiocytosis. Tissue Antigens 2004; 64: 611-615. (Pubitemid 39472928)
6. Hatta K, Morimoto A, Ishii E, Kimura H, Ueda I, Hibi S, Todo S, Sugimoto T, Imashuku S: Association of transforming growth factor-β1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases. Haematologica 2007; 92: 1470-1474. (Pubitemid 350144121)
7. Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, Binstadt BA, Filipovich A, Grom AA: Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 poymorphisms. Arthritis Rheum 2008; 58: 2892-2896.
8. Egen JG, Kuhns MS, Allison JP: CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002; 3: 611-618.
9. Loke P, Allison JP: Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells. Arthritis Res Ther 2004; 6: 208-214. (Pubitemid 40124371)
10. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Sicence 1995; 270: 985-988.
11. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseases. Nat Genet 2003; 33: 177-182. (Pubitemid 36177070)
12. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr- Smith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC: The development of Grave's disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 1999; 84: 2398-2401.
13. Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, Martins B, Andreia R, Viana JF, Crespo F, Vasconcelos C, Ferreira C, Vicente AM: Evidence for CTLA-4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 2004; 12: 620-626. (Pubitemid 39172422)
14. Pandiyan P, Hegel JK, Krueger M, Quandt D, Brunner-Weinzierl MC: High IFN-γ production of individual CD8 lymphocytes is controlled by CD152 (CTLA-4). J Immunol 2007; 178: 2132-2140. (Pubitemid 46233410)
15. Walldén J, Ilonen J, Roivainen M, Ludvigsson J, Vaarala O, ABIS Study Group: Effect of HLA genotype or CTLA-4 polymorphism on cytokine response in healthy children. Scand J Immunol 2008; 68: 345-350.
16. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, Mc- Clain K, Webb D, Winiarski J, Janka G, Histiocyte Society: HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131. (Pubitemid 44958267)
17. Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, Takeuchi T, Hara T: Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford) 2001; 40: 662-667. (Pubitemid 32621805)
18. Yang KD, Yang MY, Li CC, Lin SF, Chong MC, Wang CL, Chen RF, Lin TY: Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J Infect Dis 2001; 183: 850-856.
19. Machida H, Tsukamoto K, Wen CY, Narumi Y, Shikuwa S, Isomoto H, Takeshima F, Mizuta Y, Niikawa N, Murata I, Kohno S: Association of polymorphic alleles of CTLA-4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 2005; 11: 4188-4193. (Pubitemid 41086869)
20. Huang D, Liu L, Noren K, Xia S, Trifunovic J, Pirskanen R, Levert AK: Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 1998; 88: 192-198. (Pubitemid 28342920)
21. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J: CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001; 2: 145-152. (Pubitemid 33674879)
22. Wang XB, Kakoulidou M, Qiu Q, Giscombe R, Huang D, Pirskanen R, Lefvert AK: CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis. Genes Immun 2002; 3: 46-49. (Pubitemid 38961107)
23. Huang D, Giscombe R, Zhou Y, Pirskanen R, Levert AK: Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 2000; 105: 69-77. (Pubitemid 30125431)
24. Huang D, Giscombe R, Zhou Y, Lefvert AK: Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1 beta genes are associated with Wegener's granulomatosis. J Rheumatol 2000; 27: 397-401. (Pubitemid 30095471)
25. Zhou Y, Huang D, Paris PL, Sauter CS, Prock KA, Hoffman GS: An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis. Arthritis Rheum 2004; 50: 2645-2650. (Pubitemid 39062727)
26. Imashuku S: Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997; 66: 135-151. (Pubitemid 27360177)
27. Fujiwara F, Hibi S, Imashuku S: Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993; 15: 92-98. (Pubitemid 23061716)
28. Sun T, Zhou Y, Yang M, Hu Z, Tan W, Han X, Shi Y, Yao J, Guo Y, Yu D, Tian T, Zhou X, Shen H, Lin D: Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 2008; 68: 7025-7034.